Abstract
MicroRNAs have been discovered as regulators of gene expression and thus their potential in clinical diseasediagnostics, prognosis and therapy is being actively pursued. MicroRNAs play an important role in atherosclerosis-relateddiseases, such as cerebrovascular and cardiovascular disease. However, the effect of miR-185 and miR-146a on patientswith ischemic stroke (IS) in the different phases has not been reported. In this study, we investigated the amounts of threemiRNAs, miR-185, miR-146a, and miR-145 in blood circulation of IS patients. We enrolled 60 patients with IS in theacute or sub-acute phase and 30 healthy controls. We divided the patients into two groups, patients with ischemic stroke inthe acute phase (ISA) and patients with ischemic stroke in the subacute phase (ISS). We measured circulating miRNAsexpression by miRNA microarray and real-time polymerase chain reaction (PCR) analysis. Testing by miRNA microarrayand RT-PCR analyses showed that miR-145 levels in healthy subjects were similar to patients with IS, whereas miR-146aand miR-185 were present with quite low abundance in ISA compared with healthy individuals; moreover, we found thatmiR-146a levels were downregulated in ISA but upregulated in ISS which may help provide new insights into the diagnosisand therapy of IS.
Keywords:MicroRNAs, blood, MiR-185, MiR-146a, ischemic stroke, phase.
Current Neurovascular Research
Title:Differential Regulation of microRNAs in Patients with Ischemic Stroke
Volume: 12Issue: 3
Author(s):Sheng-Hua Li, Sheng-You Su and Jing-Li Liu
Affiliation:
Keywords:MicroRNAs, blood, MiR-185, MiR-146a, ischemic stroke, phase.
Abstract: MicroRNAs have been discovered as regulators of gene expression and thus their potential in clinical diseasediagnostics, prognosis and therapy is being actively pursued. MicroRNAs play an important role in atherosclerosis-relateddiseases, such as cerebrovascular and cardiovascular disease. However, the effect of miR-185 and miR-146a on patientswith ischemic stroke (IS) in the different phases has not been reported. In this study, we investigated the amounts of threemiRNAs, miR-185, miR-146a, and miR-145 in blood circulation of IS patients. We enrolled 60 patients with IS in theacute or sub-acute phase and 30 healthy controls. We divided the patients into two groups, patients with ischemic stroke inthe acute phase (ISA) and patients with ischemic stroke in the subacute phase (ISS). We measured circulating miRNAsexpression by miRNA microarray and real-time polymerase chain reaction (PCR) analysis. Testing by miRNA microarrayand RT-PCR analyses showed that miR-145 levels in healthy subjects were similar to patients with IS, whereas miR-146aand miR-185 were present with quite low abundance in ISA compared with healthy individuals; moreover, we found thatmiR-146a levels were downregulated in ISA but upregulated in ISS which may help provide new insights into the diagnosisand therapy of IS.
Export Options
About this article
Cite this article as:
Li Sheng-Hua, Su Sheng-You and Liu Jing-Li, Differential Regulation of microRNAs in Patients with Ischemic Stroke, Current Neurovascular Research 2015; 12 (3) .https://dx.doi.org/10.2174/1567202612666150605121709
DOI https://dx.doi.org/10.2174/1567202612666150605121709 | Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher | Online ISSN 1875-5739 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
- Potential Role of microRNAs in Cardiovascular Disease: Are They up to Their Hype?
Current Cardiology ReviewsWhy Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Current NeuropharmacologyAn Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug TargetsEditorial (Thematic Issue: Novel Insights into the Role of Anesthetics and Opioids in Organ or Tissue Protection)
Current Pharmaceutical Design Platelet Function in Inflammatory Diseases: Insights from Clinical Studies
Inflammation & Allergy - Drug Targets (Discontinued)Potential Effect of Anti-Inflammatory Treatment on Reducing the Cardiovascular Risk in Rheumatoid Arthritis
Current Vascular Pharmacology Role of Platelet Signaling in Thrombus Stabilization: Potential Therapeutic Implications
Current Signal Transduction TherapyEndogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Cardiovascular Drug Development Using Radiopharmaceuticals
Current Pharmaceutical Design L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued)Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular PharmacologyBeneficial Effects of the Mediterranean Diet on Metabolic Syndrome
Current Pharmaceutical DesignInfertile Women's Perceptions of Infertility: A Phenomenological StudyBased on Metaphor Analysis
Current Women`s Health Reviews Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry The IL-17 Family of Cytokines - Applications in Respiratory Medicine and Allergology
Recent Patents on Inflammation & Allergy Drug Discovery Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Current Pharmaceutical DesignMeet Our Editorial Board Member
Medicinal ChemistryStatins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage
Current Molecular PharmacologyMethylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance
Current Pharmaceutical DesignGenetic Alleles Associated with SLE Susceptibility and Clinical Manifestations in Hispanic Patients from the Dominican Republic
Current Molecular Medicine
[8]ページ先頭